La Jolla Pharmaceutical Profit Margin

La Jolla Pharmaceutical (LJPC) currently reports a profit margin of 3.27% as of June 2022. That compares with 4.15% in the prior-year period — down 21.1% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore La Jolla Pharmaceutical's profit margin history and peer comparisons.

La Jolla Pharmaceutical's profit margin decreased from 4.15% to 3.27% — a 21.1% year-over-year decrease (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

La Jolla Pharmaceutical's profit margin of 3.27% is lower than the Healthcare sector average of 15.29%. That is roughly 78.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but La Jolla Pharmaceutical's current 3.27% should be judged against Healthcare norms (sector average: 15.29%) and against LJPC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 3.27%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for La Jolla Pharmaceutical, and consider following LJPC for alerts when major investors trade the stock.